A delivery system that uses lipid nanoparticles to sneak proteins into cells can accomplish the same feat with smuggling therapeutic antibodies, new research has found.
Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults.
A $13.3 million grant from the NIH will support efforts to reveal how immune cells communicate within living tissues, which could shape new approaches for treating inflammatory diseases, autoimmune disorders and infections.
A new single-protein analysis technique gives researchers an unprecedented ability to study scramblases, and could someday be useful in devising new strategies against multiple diseases.
Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria.
A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.
The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, according to a new study.
While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and the University of Texas at Austin.